SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-031764
Filing Date
2019-05-21
Accepted
2019-05-21 16:44:03
Documents
1
Period of Report
2019-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 5908
  Complete submission text file 0001209191-19-031764.txt   7329
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REGULUS THERAPEUTICS INC. 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
Witz Pascale (Reporting) CIK: 0001703723 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35670 | Film No.: 19842935